These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15208653

  • 1. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA, Szentirmay MN, Hermeking H, Sawadogo M.
    Oncogene; 2004 Aug 12; 23(36):6125-35. PubMed ID: 15208653
    [Abstract] [Full Text] [Related]

  • 2. Loss of USF transcriptional activity in breast cancer cell lines.
    Ismail PM, Lu T, Sawadogo M.
    Oncogene; 1999 Sep 30; 18(40):5582-91. PubMed ID: 10523835
    [Abstract] [Full Text] [Related]

  • 3. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 4. The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells.
    Szentirmay MN, Yang HX, Pawar SA, Vinson C, Sawadogo M.
    J Biol Chem; 2003 Sep 26; 278(39):37231-40. PubMed ID: 12857727
    [Abstract] [Full Text] [Related]

  • 5. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT, Yang HT, Wang TC, Cheng AJ.
    Mol Carcinog; 2005 Nov 26; 44(3):183-92. PubMed ID: 16010690
    [Abstract] [Full Text] [Related]

  • 6. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL, Miron A, Andersen LM, Iglehart JD, Marks JR.
    Oncogene; 1999 Oct 28; 18(44):6000-12. PubMed ID: 10557089
    [Abstract] [Full Text] [Related]

  • 7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 8. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M, Moriuchi H, Margolis DM, Fauci AS.
    J Immunol; 1999 May 15; 162(10):5986-92. PubMed ID: 10229837
    [Abstract] [Full Text] [Related]

  • 9. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec 15; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 10. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 11. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.
    Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Lüscher B.
    Genes Dev; 2001 Aug 15; 15(16):2042-7. PubMed ID: 11511535
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.
    Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, Hunter LJ, Sutherland RL, Musgrove EA.
    Oncogene; 2005 Jan 13; 24(3):381-9. PubMed ID: 15489884
    [Abstract] [Full Text] [Related]

  • 13. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.
    Cancer Res; 2006 May 15; 66(10):5330-7. PubMed ID: 16707459
    [Abstract] [Full Text] [Related]

  • 14. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE.
    Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917
    [Abstract] [Full Text] [Related]

  • 15. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR, Qi L, Higgins PJ.
    J Cell Physiol; 2005 Apr 29; 203(1):156-65. PubMed ID: 15372465
    [Abstract] [Full Text] [Related]

  • 16. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E, Crémisi C.
    Oncogene; 1999 Oct 07; 18(41):5662-71. PubMed ID: 10523846
    [Abstract] [Full Text] [Related]

  • 17. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 07; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 18. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE.
    Oncogene; 2000 Nov 16; 19(48):5498-506. PubMed ID: 11114727
    [Abstract] [Full Text] [Related]

  • 19. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V, Leff T, Saltiel AR.
    Mol Cell Neurosci; 1994 Jun 16; 5(3):277-82. PubMed ID: 8087425
    [Abstract] [Full Text] [Related]

  • 20. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K, Okamoto K, Tanaka Y, Umata T, Ohnuma M, Moroi M, Kimura H, Tsuneoka M.
    Int J Oncol; 2008 Dec 16; 33(6):1271-80. PubMed ID: 19020761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.